Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 6/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | UBE2N | P61088 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | RAD52 | P43351 | 2/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.45 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8655138 | 0.87 | MAPK1 (0.56) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL8473986 | 0.85 | MAPK1 (0.57) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL988255 | 0.82 | MAPK1 (0.55) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL8470405 | 0.82 | MAPK1 (0.67) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL29443083 | 0.81 | MAPK1 (0.54) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| Propane SCHEMBL10703212 | 0.81 | MAPK1 (0.54) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL133717 | 0.81 | MAPK1 (0.54) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL5145870 | 0.79 | MAPK1 (0.61) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL6682777 | 0.79 | MAPK1 (0.63) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL8598929 | 0.79 | MAPK1 (0.59) | MAPK1NPSR1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8105668-B2 | Crystalline form of 2-(4,6-bis-biphenyl-4-yl-1,3,5-triazin-2-yl)-5-(2-ethyl-(n)-hexyloxy)phenol | BASF SE (DE) | 2012-01-31 | — | — | US | disclosed |
| US-20110027509-A1 | CRYSTALLINE FORM OF 2-(4,6-BIS-BIPHENYL-4-YL-1,3,5-TRIAZIN-2-YL)-5-(2-ETHYL-(N)-HEXYLOXY)PHENOL | BASF SE (US) | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110027509-A1 | CRYSTALLINE FORM OF 2-(4,6-BIS-BIPHENYL-4-YL-1,3,5-TRIAZIN-2-YL)-5-(2-ETHYL-(N)-HEXYLOXY)PHENOL | CRYZ, H1-4, H1-2 | MAPK1 3227/4885NPSR1 3939/4885SMN1; SMN2 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.